Aims of the program
The Human Papillomavirus (HPV) Vaccination Program aims to prevent cancers caused by HPV, including cancers of the:
The program also aims to prevent warts caused by HPV. The immunization schedule includes 1 dose of Gardasil 9, followed by 1 dose of Cervarix (6 months later).
These 2 doses produce a very strong immune system response to HPV types 16 and 18. HPV 16 is responsible for most HPV-related cancers, especially cancers that affect men. Furthermore, the combination of these 2 vaccines also provides immunity against the 7 other types of HPV in Gardasil 9.
Québec is the only place where these two vaccines are used for HPV immunization in children. Based on serious studies, Québec was also the only place where two doses of vaccine were given instead of three when HPV immunization was introduced in 2008. Most countries do the same as Québec now.
To find out more about the vaccines used and the benefits of immunization, go to the page Human Papillomavirus (HPV) Vaccines.
Last update: October 24, 2018